title: Conventional megavoltage radiotherapy in the management of malignant epithelial tumours of the parotid gland.
abstract: This is an evaluation of definitive conventional megavoltage radiotherapy in a consecutive series of 35 patients presenting malignant epithelial tumours of the parotid gland. In this series, the 5-year actuarial locoregional control rate was 41% with a 5-year crude survival rate of 36%. The results are analyzed according to tumour presentation and tumour doses. Six of 15 patients with tumours larger than 6 cm have had a lasting locoregional control. During the same period 43 other patients received radiotherapy as a post-operative modality. Results obtained in this group confirm the previously published data. While recent studies tend to demonstrate the specific efficacy of high LET radiation in the management of locally advanced salivary gland tumours, radical conventional radiotherapy can still be employed with a curative intent when neutron facilities are not available.
authors.affiliation: Department of Radiotherapy, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Piedbois
authors.forename: J P
authors.initials: JP
authors.lastname: Bataini
authors.forename: P
authors.initials: P
authors.lastname: Colin
authors.forename: J C
authors.initials: JC
authors.lastname: Durand
authors.forename: C
authors.initials: C
authors.lastname: Jaulerry
authors.forename: F
authors.initials: F
authors.lastname: Brunin
authors.forename: D
authors.initials: D
authors.lastname: Pontvert
mesh_terms: D000328:Adult; D003037:Cobalt Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010307:Parotid Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D011882:Radiotherapy, High-Energy / Q000009:adverse effects; D012074:Remission Induction
chemical_list: D003037:Cobalt Radioisotopes